美国 · SEC FORM 4
Yarrow Bioscience, Inc.
YARW · Nasdaq · CIK 0001566044 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
10 同一窗口内观察到的 Form 4 交易行
0 sales · 10 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-01-15 · LEPORE PATRICK G.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 189,586
- 上期报告
- 126,528
- 日均成交量
- 158,363
- 回补天数
- 1.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-01-15 | LEPORE PATRICK G | 买入 (P) | Common Stock | 15,000 | USD 2.92 | USD 43,800 | SEC 申报 ↗ |
| 2023-11-15 | LEPORE PATRICK G | 买入 (P) | Common Stock | 13,000 | USD 3.91 | USD 50,830 | SEC 申报 ↗ |
| 2023-03-20 | LEPORE PATRICK G | 买入 (P) | Common Stock | 20,000 | USD 2.48 | USD 49,600 | SEC 申报 ↗ |
| 2023-03-20 | Harsch Mutya | 买入 (P) | Common Stock | 10,000 | USD 2.50 | USD 25,000 | SEC 申报 ↗ |
| 2021-11-30 | LEPORE PATRICK G | 买入 (P) | Common Stock | 12,500 | USD 1.02 | USD 12,750 | SEC 申报 ↗ |
| 2021-08-25 | LEPORE PATRICK G | 买入 (P) | Common Stock | 12,500 | USD 1.60 | USD 20,000 | SEC 申报 ↗ |
| 2021-05-26 | LEPORE PATRICK G | 买入 (P) | Common Stock | 12,500 | USD 3.60 | USD 45,000 | SEC 申报 ↗ |
| 2021-03-15 | LEPORE PATRICK G | 买入 (P) | Common Stock | 12,500 | USD 7.41 | USD 92,625 | SEC 申报 ↗ |
| 2021-01-28 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 4,219,409 | USD 2.37 | USD 9,999,999 | SEC 申报 ↗ |
| 2020-12-03 | LEPORE PATRICK G | 买入 (P) | Common Stock | 50,000 | USD 1.71 | USD 85,500 | SEC 申报 ↗ |
| 2020-09-08 | Saik Andrew | 买入 (P) | Common Stock | 40,000 | USD 1.46 | USD 58,400 | SEC 申报 ↗ |
| 2020-09-08 | Domzalski David | 买入 (P) | Common Stock | 75,000 | USD 1.38 | USD 103,500 | SEC 申报 ↗ |
| 2020-06-09 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 2,702,702 | USD 1.85 | USD 4,999,999 | SEC 申报 ↗ |
Form 4 申报证据
14 transaction lines in the latest 365-day window; 204 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-29 | RTW Fund Group GP, LLC; WONG RODERICK | J (J) | Common Stock | 133,290 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-23 | Zeronda Tyler | 代扣税 (F) | Common Stock | 22,516 | USD 0.90 | USD 20,264 | SEC 申报 ↗ |
| 2026-07-23 | Stuart Iain | 代扣税 (F) | Common Stock | 15,405 | USD 0.90 | USD 13,864 | SEC 申报 ↗ |
展开近期 Form 4 证据 (14 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-29 | RTW Fund Group GP, LLC; WONG RODERICK | J (J) | Common Stock | 133,290 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-23 | Zeronda Tyler | 代扣税 (F) | Common Stock | 22,516 | USD 0.90 | USD 20,264 | SEC 申报 ↗ |
| 2026-07-23 | Stuart Iain | 代扣税 (F) | Common Stock | 15,405 | USD 0.90 | USD 13,864 | SEC 申报 ↗ |
| 2026-07-23 | Harsch Mutya | 代扣税 (F) | Common Stock | 22,516 | USD 0.90 | USD 20,264 | SEC 申报 ↗ |
| 2026-07-23 | Domzalski David | 代扣税 (F) | Common Stock | 79,391 | USD 0.90 | USD 71,452 | SEC 申报 ↗ |
| 2026-06-30 | Zeronda Tyler | 代扣税 (F) | Common Stock | 3,464 | USD 0.65 | USD 2,252 | SEC 申报 ↗ |
| 2026-06-30 | Stuart Iain | 代扣税 (F) | Common Stock | 2,370 | USD 0.65 | USD 1,540 | SEC 申报 ↗ |
| 2026-06-30 | Harsch Mutya | 代扣税 (F) | Common Stock | 3,464 | USD 0.65 | USD 2,252 | SEC 申报 ↗ |
| 2026-06-30 | Domzalski David | 代扣税 (F) | Common Stock | 12,214 | USD 0.65 | USD 7,939 | SEC 申报 ↗ |
| 2026-05-29 | Domzalski David | 奖励／授予 (A) | Common Stock | 30,791 | USD 0.31 | USD 9,545 | SEC 申报 ↗ |
| 2025-12-31 | Zeronda Tyler | 代扣税 (F) | Common Stock | 7,858 | USD 0.58 | USD 4,558 | SEC 申报 ↗ |
| 2025-12-31 | Stuart Iain | 代扣税 (F) | Common Stock | 2,448 | USD 0.58 | USD 1,420 | SEC 申报 ↗ |
| 2025-12-31 | Harsch Mutya | 代扣税 (F) | Common Stock | 3,579 | USD 0.58 | USD 2,076 | SEC 申报 ↗ |
| 2025-12-31 | Domzalski David | 代扣税 (F) | Common Stock | 12,684 | USD 0.58 | USD 7,357 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | YARW |
| CIK | 0001566044 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 204 transaction lines from 2020-03-09 to 2026-07-29 13 P purchase lines · 4 S sale lines · 187 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.